✦ LIBER ✦

9140 Evaluation of treatment adherence, persistance, and quality of life in patients with advanced non-small cell lung cancer (ANSCLC) treated with erlotinib (e) as second-line therapy

✍ Scribed by Gebbia, V.; Russo, P.; Mancuso, G.; Arcara, C.; Borsellino, N.

Book ID: 123388315
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 48 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71853-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

50 IMPLEMENTATION OF ADHERENCE TO ERLOTI

50 IMPLEMENTATION OF ADHERENCE TO ERLOTINIB (E) AS SECOND-LINE THERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER (ANSCLC)

✍ V. Gebbia; G. Bellavia; P. Russo; G.L. Banna; F. Ferraù; P. Tralongo; N. Borsell 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Clinical surrogate markers of survival i

Clinical surrogate markers of survival in advanced non-small cell lung cancer (NSCLC) patients treated with second–third line erlotinib

✍ Cedrés, Susana; Prat, Aleix; Martínez, Pablo; Pallisa, Esther; Sala, Gemma; Andr 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 341 KB

Randomized Phase III Trial of Erlotinib

Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA)

✍ Kawaguchi, T.; Ando, M.; Asami, K.; Okano, Y.; Fukuda, M.; Nakagawa, H.; Ibata, 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 183 KB

Phase-II trial of taxotere (TXT) and Nav

Phase-II trial of taxotere (TXT) and Navelbine (N) as first-line therapy in patients (PTS) with advanced non-small cell lung cancer (ANSCLC)

✍ O'Rourke, M.; Garfield, D.; Ellis, P. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Activity and safety of erlotinib as seco

Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trial

✍ David Rossi; Donatella Dennetta; Marcello Ugolini; Vincenzo Catalano; Paolo Ales 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 129 KB

Phase II study of weekly paclitaxel as s

Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer

✍ Ceresoli, Giovanni Luca; Gregorc, Vanesa; Cordio, Stefano; Bencardino, Katia Bru 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 117 KB